Ciclesonide

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Use dmy dates Template:Cs1 config Template:Drugbox

Ciclesonide, sold under the brand name Omnaris among others, is a glucocorticoid used to treat asthma and allergic rhinitis.

Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.[1]

It was patented in 1990 and approved for medical use in 2005.[2] The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006.[3] It is on the World Health Organization's List of Essential Medicines.[4]

Society and culture

Brand names

It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, Zetonna, and Alvesco for hay fever in the US and Canada.

References

Template:Reflist

Further reading

Template:Refbegin

  • Script error: No such module "citation/CS1".

Template:Refend

Template:Glucocorticoids and antiglucocorticoids Template:Asthma and copd rx Template:Nasal preparations Template:Glucocorticoid receptor modulators Template:Portal bar Template:Authority control

  1. Script error: No such module "Citation/CS1".
  2. Script error: No such module "citation/CS1".
  3. Script error: No such module "citation/CS1".
  4. Script error: No such module "citation/CS1".